Delivra Health Brands (TSE:DHB)
:DHB
Want to see TSE:DHB full AI Analyst Report?
DHB Stock Chart & Stats
C$0.14
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.14
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.12 - C$0.37
Previous CloseN/A
Volume20.60K
Average Volume (3M)26.13K
Market Cap
C$3.91M
Enterprise ValueC$2.78M
Total Cash (Recent Filing)C$3.23M
Total Debt (Recent Filing)C$2.26M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding31,261,782
10 Day Avg. Volume58,945
30 Day Avg. Volume26,134
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.60Price Target Upside328.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$14.97M
Bulls Say, Bears Say
Bulls Say
Healthy Gross Margin (~50%)Sustained gross margins near 50% indicate the core product formulations command substantial per-unit profitability. That structural margin provides a durable buffer versus input cost swings and, if scale improves, can convert to positive operating earnings as SG&A is leveraged over higher revenue.
Manageable Leverage (D/E ~0.5–0.6)Reported debt levels and a moderate debt-to-equity ratio give the company financial flexibility relative to peers. Manageable leverage reduces near-term solvency risk and preserves capacity to fund commercialization, R&D, or working capital without immediate dilution if cash generation stabilizes.
Multi-year Revenue Expansion (2021–2025 Annual)A multi-year revenue expansion shows the business has been gaining distribution or customer traction over time. That structural top-line growth supports the case that product-market fit and commercialization capabilities exist, enabling potential operating leverage as growth continues or margins are preserved.
Bears Say
Ongoing Losses (TTM Net Margin ~-6%)Persistent negative net margins and slightly negative EBIT mean the company is not yet self-sustaining operationally. Continued losses erode equity, limit reinvestment capacity, and increase dependence on external capital; absent a sustainable path to profitability, financial stability is at risk.
Volatile, Negative Cash GenerationInconsistent and negative operating/free cash flow constrains the company’s ability to fund inventory, marketing, or product launches from internal resources. This volatility raises refinancing and execution risk over the coming months, limiting safe runway for scaling initiatives without outside financing.
Recent Revenue Deceleration (TTM -2.4%)A recent TTM revenue decline after multi-year growth signals potential channel saturation, weakened demand, or execution challenges. With tight profitability, even modest revenue dips reduce operating leverage and can quickly reverse margin improvements achieved in prior years.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.12 and its highest was C$0.37 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$3.91M.
When is Delivra Health Brands’s upcoming earnings report date?
Delivra Health Brands’s upcoming earnings report date is May 27, 2026 which is in 5 days.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on Feb 27, 2026. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Delivra Health Brands overvalued?
According to Wall Street analysts Delivra Health Brands’s price is currently Undervalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Delivra Health Brands
Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The company is involved in selling of cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It offers its products under LivRelief, Dream Water, and LivRelief infused brand names. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
DHB Stock 12 Month Forecast
Average Price Target
C$0.60
▲(328.57% Upside)
Technical Analysis
Options Prices
Currently, No data available
---